We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Michael R. Klapal
Michael R. Klapal
Products
PRODUCTS
Unette Corp
Michael R. Klapal
Price:
$117.00
View
Excellium Pharmaceutical, Inc.
Michael R. Klapal
Price:
$117.00
View
Genzyme, Division of Sanofi Company
Michael R. Klapal
Price:
$117.00
View
Amneal Pharmaceuticals LLC
Michael R. Klapal
Price:
$117.00
View
Pharmacy Creations
Michael R. Klapal
and
Douglas C. Kovacs
Price:
$117.00
View
Ashland Specialty Ingredients
Michael R. Klapal
and
Nikki Ramirez
Price:
$117.00
View
West-ward Pharmaceutical Corp.
Michael R. Klapal
and
Lauren L. Vajo
Price:
$117.00
View
PF Laboratories, Inc.
Michael R. Klapal
Price:
$117.00
View
Contract Coating, Inc.
Michael R. Klapal
Price:
$117.00
View
API, Inc.
Michael R. Klapal
Price:
$117.00
View
View All Products by Michael R. Klapal
Upcoming Events
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Senate HELP Committee, Sanders Investigating Novo Nordisk Price Gouging in US
Philips Gets Warning Letter for CT Manufacturing Site in China
Draft Guidance Aids in Writing NDA, ANDA Drug Component List to Speed Approval
Problem-Laden Syringes’ Marketing Earns Cardinal Health FDA Warning Letter
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More